Michael Henry Fiore Sells 1,781 Shares of HealthEquity (NASDAQ:HQY) Stock

Key Points

• Michael Henry Fiore, EVP of HealthEquity, sold 1,781 shares of the company's stock at an average price of $88.21, resulting in a transaction worth $157,102.01.
• Following the sale, Fiore's remaining ownership stands at 49,795 shares, with a total value of approximately $4.39 million, reflecting a 3.45% decrease in his position.
• HealthEquity's stock price has recently risen, trading up 4.1% to $92.09, while analysts have varying ratings with a consensus target price of around $121.31.

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) EVP Michael Henry Fiore sold 1,781 shares of HealthEquity stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the transaction, the executive vice president owned 49,795 shares in the company, valued at approximately $4,392,416.95. This trade represents a 3.45% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

HealthEquity Trading Up 4.1%

Shares of NASDAQ:HQY traded up $3.59 during trading on Wednesday, reaching $92.09. 1,003,838 shares of the stock were exchanged, compared to its average volume of 1,031,256. The firm has a market cap of $7.93 billion, a price-to-earnings ratio of 55.81, a price-to-earnings-growth ratio of 1.26 and a beta of 0.47. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. HealthEquity, Inc. has a 12-month low of $74.07 and a 12-month high of $116.65. The firm's 50-day moving average price is $91.84 and its 200 day moving average price is $93.83.

Analyst Ratings Changes

Several brokerages have recently weighed in on HQY. Royal Bank Of Canada raised their target price on HealthEquity from $109.00 to $110.00 and gave the company an "outperform" rating in a research note on Wednesday, September 3rd. Raymond James Financial restated a "strong-buy" rating and set a $120.00 target price (up from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Weiss Ratings reissued a "hold (c+)" rating on shares of HealthEquity in a research report on Wednesday. JPMorgan Chase & Co. boosted their target price on shares of HealthEquity from $125.00 to $126.00 and gave the stock an "overweight" rating in a research report on Wednesday, September 3rd. Finally, Barrington Research reissued an "outperform" rating and issued a $125.00 target price on shares of HealthEquity in a research report on Friday, August 29th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $121.31.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Invesco Ltd. grew its position in HealthEquity by 50.6% in the 1st quarter. Invesco Ltd. now owns 2,446,198 shares of the company's stock worth $216,171,000 after purchasing an additional 821,425 shares during the last quarter. Westfield Capital Management Co. LP lifted its stake in shares of HealthEquity by 124.6% in the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company's stock worth $132,543,000 after acquiring an additional 701,819 shares during the period. Goldman Sachs Group Inc. raised its holdings in HealthEquity by 1.4% during the first quarter. Goldman Sachs Group Inc. now owns 1,133,166 shares of the company's stock worth $100,138,000 after purchasing an additional 15,458 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in HealthEquity by 2.6% in the second quarter. Charles Schwab Investment Management Inc. now owns 1,129,115 shares of the company's stock worth $118,286,000 after purchasing an additional 28,145 shares during the period. Finally, Geneva Capital Management LLC lifted its position in HealthEquity by 6.2% in the second quarter. Geneva Capital Management LLC now owns 1,108,241 shares of the company's stock worth $116,099,000 after purchasing an additional 64,487 shares during the period. Institutional investors own 99.55% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.